October
24
  2:53:02 AM

UK babies aborted for trivial defects

More than 100 babies with minor disabilities, such as a cleft palate or club foot, were aborted in just one region of England between 2002 and 2005. According to government figures 54 babies in south- west England with club feet, 37 with cleft palates or lips, and 26 with extra or webbed fingers or toes were terminated.

All of these defects could be corrected with minor surgery. Club feet is one of the commonest birth defects, but it can be corrected without surgery, with splints, plaster casts and boots. However, some parents and doctors still believe that it is a serious birth defect.

The UK's Abortion Act allows termination at any stage of pregnancy if two doctors agree that there is a "substantial risk" of the child being "serious handicapped". What constitutes "substantial risk" is left to the doctors' discretion, and some fear the definition of "handicap" is widening as scanning technology develops.

The data on birth defects were released as a Parliamentary committee considers whether to recommend scrapping a 24-week upper limit for abortions. It is also considering whether a requirement for the written approval of two doctors should be abolished and whether nurses should be permitted to perform early-stage abortions.


 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Neuroscience as the military’s new weapon
9 Feb 2012
Single-embryo transfers? Fugedaboudit, says NY IVF doctor
9 Feb 2012
Dutch celebrate a decade of euthanasia with a film festival
6 Feb 2012
Lost in surrogacy’s Bermuda Triangle
3 Feb 2012
Scores of UK patients die with bedsores, infections and malnutrition
3 Feb 2012

 Tags
sperm donation, China, informed consent, law, clinical trials, organ donation, organ trafficking, sex selection, Canada, US, euthanasia, human drama, genetic testing, abortion, assisted suicide, UK, research, bioethics, India, suicide, embryonic stem cells, HFEA, neuroscience, surrogacy, commercialization, Australia, Down syndrome, IVF, Netherlands, stem cells,